Latest Research in Hepatic Fibrosis and Metabolic Dysregulation

Top Research Topics in Hepatic Fibrosis and Metabolic Dysregulation

• Liver Disease Diagnosis and Treatment — 70 papers
• Thyroid Disorders and Treatments — 16 papers
• Cystic Fibrosis Research Advances — 10 papers
• Metabolomics and Mass Spectrometry Studies — 9 papers
• Genetic Associations and Epidemiology — 8 papers
• Metabolism and Genetic Disorders — 4 papers
• Pancreatitis Pathology and Treatment — 4 papers
• Neonatal Health and Biochemistry — 3 papers
• Obstructive Sleep Apnea Research — 3 papers
• Nutrition and Health in Aging — 3 papers

Highest-Cited Papers

1. Personal-MetaboHealth, an actionable health check in middle age, is improved by an effective lifestyle intervention in those at risk (1 citations)
2. COMPARATIVE STUDIES OF HYPOTHYROIDISM AND HYPERTHYROIDISM
3. Dietary intake, metabolic control and growth in patients with organic acidemia and urea cycle disorders
4. COMPARATIVE STUDIES OF HYPOTHYROIDISM AND HYPERTHYROIDISM
5. Clinical characteristics of thyroid structure and functional abnormalities in bipolar disorder and their association with mood symptoms: a retrospective cross-sectional study
6. Genetic Susceptibility Versus Fibrosis Progression in North Indian Metabolic Dysfunction-Associated Steatotic Liver Disease: Distinct Roles of APOC3 and PNPLA3 in a Candidate Gene Study.
7. Lean MAFLD and MASLD represent an underrecognized high risk phenotype beyond body mass index
8. Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization
9. Metabolic reprogramming in diabetic panvascular disease: Molecular mechanism and therapeutic strategies
10. Osteoprotegerin lowers type 2 diabetes risk: insights from drug-target Mendelian randomization and mediation analysis
11. Conditional deep generative modeling of blood-based infrared spectra enables controlled in-silico phenotyping studies
12. Children's and caregivers' experiences, information needs, and willingness to change lifestyle in metabolic dysfunction‐associated steatotic liver disease care: A multicenter study across Europe
13. Liver Fibrosis and IRS1 rs2972146 Are Associated With Weight Loss Response After Metabolic Bariatric Surgery
14. Residual lipid-related proteomic and metabolomic signatures associated with major adverse cardiovascular events after revascularization in peripheral artery disease
15. Increased risk of steatotic liver disease, major adverse liver outcomes, cardiovascular events and mortality in pheochromocytoma: a model of chronically elevated sympathetic tone
16. 0037Nonalcoholic Fatty Liver Disease Severity and Subclinical Cardiac Dysfunction in Prediabetes: A Systematic Review
17. The Association of Cardiovascular Disease (CVD) with Progression of Advanced Fibrosis Risk in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
18. Gene–Environment Interaction Mendelian Randomization Reveals Statin-Dependent Associations Between Metabolites and Lipid Traits
19. Sarcopenia and Skeletal Muscle Dysfunction in Liver Cirrhosis: Clinical Perspectives of Myostatin Inhibition
20. Management of Eprinomectin Neurotoxicosis in Cats

Sub-Regions

• Thyroid Disorders and Treatments — 43 papers
• Liver Disease Diagnosis and Treatment — 38 papers
• Metabolomics and Mass Spectrometry Studies — 29 papers
• Cystic Fibrosis Research Advances — 22 papers
• Food Security and Health in Diverse Populations — 17 papers
• Down syndrome and intellectual disability research — 6 papers